Uses, Side Effects, Price of SEVMED 800 Tablet 10's:

SEVMED 800 Tablet contains Sevelamer which belongs to the group of medicines called Phosphate Binding Agents. It is used to control the serum phosphorous levels in patients with long-term kidney disease who are on dialysis. Renal failure is the most common cause of high phosphorous levels, as there is reduced filtration of inorganic phosphate, increasing serum levels.

During treatment, your doctor might ask you to take certain tests to avoid any untoward side effects. Maintain the diet as advised by your doctor. SEVMED 800 Tablet is not recommended for use in patients having low levels of phosphorus in the blood and bowel obstruction. SEVMED 800 Tablet should be used with caution in patients who have trouble swallowing, motility problems in stomach and bowel, and in those who have undergone major bowel surgery.

SEVMED 800 Tablet should be used in pregnant women only if your doctor finds it clearly necessary. It is unknown whether SEVMED 800 Tablet is excreted in breast milk and may affect your baby, so consult your doctor before taking it during breastfeeding. SEVMED 800 Tablet is not intended for use in children and adolescents (below 18 years of age).

The most common side effects of taking SEVMED 800 Tablet are constipation, vomiting, upper abdominal pain, nausea, diarrhea, indigestion, flatulence (gas), etc. Ask for your doctor’s advice if any of these worsen or doesn’t improve.

USES OF SEVMED 800 Tablet 10's

• Used to control the serum phosphorous levels in patients with chronic kidney disease who are on dialysis

Benefits of SEVMED 800 Tablet 10's:

SEVMED 800 Tablet is a Chelating agent which helps in reducing the phosphorus levels in the blood by binding to the phosphate that enters the body with food and preventing its absorption.

Take SEVMED 800 Tablets as advised by your physician. Swallow it with a glass of water. Do not crush or chew the medicine. Your doctor will decide on an appropriate dose and duration of SEVMED 800 Tablet for you depending upon your age, body weight, and disease condition. Do not stop taking SEVMED 800 Tablets unless your doctor advises you to stop.

SIDE EFFECTS OF SEVMED 800 Tablet 10's:

The majority of adverse effects are temporary and go away as your body becomes used to the medication. If they persist or you're concerned about them, speak with your doctor.

• Nausea, vomiting, upper abdominal pain
• Diarrhea, constipation
• Indigestion, flatulence
• Blockage in the intestine (abdominal pain, severe bloating, swelling or cramps, severe constipation)
• Allergic reaction (rash, swelling, hives, trouble breathing)
• Serious inflammation of the large bowel (severe stomach pain, stomach or intestine disorders, blood in the stool, crystal deposit in the intestine)

Caution :

• Keep out of reach of children.
• Keep away from direct sunlight.

FAQs :ABOUT SEVMED 800 Tablet 10's

Q1 What is SEVMED 800 Tablet and why is it prescribed? SEVMED 800 Tablet contains Sevelamer which belongs to the group of medicines called Phosphate Binding Agents. It is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

Q2 Can I stop taking SEVMED 800 Tablet on my own? You should not stop taking SEVMED 800 Tablets until your doctor advises you to. Taking SEVMED 800 Tablet is important to maintain an appropriate phosphate level in the blood. Stopping SEVMED 800 Tablet may lead to consequences such as calcification in the blood vessels making it hard for your body to pump blood, itchy skin, red eyes, bone pain, and fractures. If you wish to discontinue taking SEVMED 800 Tablet, contact your doctor first.

Q3 What other precautions shall I take while taking SEVMED 800 Tablet? Due to either your kidney condition or your dialysis treatment, you may have disturbed levels of calcium, vitamins A, E, K, D, folic acid, and bicarbonates in the blood. SEVMED 800 Tablet should be used with calcium supplements and vitamin D to prevent the development of bone disease. Your doctor might check these levels in your blood frequently.